SynthesisClinical and experimental medicine2023

Comparative efficacy and safety of first-line neoadjuvant treatments in triple-negative breast cancer: systematic review and network meta-analysis.

Jinming Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.